2022

Tri-Valley Life Sciences Summit

The Tri-Valley Life Sciences Summit is back!

Hosted by Veeva Systems and presented by Mirador Capital Partners and Tri-Valley Ventures.

October 13, 2022 | 5:00 – 8:30pm | Veeva Systems | Pleasanton, CA

The program begins with James Langford, Principal at Tri-Valley Ventures, sharing information on the investment landscape and venture capital activity for life sciences companies in the Tri-Valley.

The keynote event is a fireside chat with Ben Hindson, CSO, co-founder, and president of 10x Genomics, discussing the various personal and company transitions going from 10x Genomics’ foundation to its current state as a publicly-traded company.

This will be followed by a panel discussion by Tri-Valley life sciences entrepreneurs and ecosystem leaders about how they overcame or corrected course as they faced challenges while building their companies.

Connect with the Tri-Valley life sciences ecosystem.

Over 250 local life sciences entrepreneurs and professionals attended the second annual Tri-Valley Life Sciences Summit, hosted at Veeva Systems in Pleasanton in 2019. View the 2019 program and sponsors here.

Event Schedule

The Summit is designed to give busy professionals concrete takeaways they can incorporate into their work immediately, as well as plenty of opportunities to connect with peers. This year we have structured the program to provide high-value content for early-stage startups as well as high-growth, later-stage companies. A snapshot of the agenda is to to the right (or below).

5:00 pm

Networking

5:45 pm

Opening – TBD

6:00 pm

Life Sciences Investment Landscape – James Langford, Principal, Tri-Valley Ventures

6:15 - 6:45pm

Keynote – Fireside Chat with Ben Hindson, CSO, 10x Genomics

6:45 - 7:15 pm

Panel Discussion with Life Sciences Entrepreneurs

7:15 - 7:30 pm

Introduction to Recruiting Event Sponsors

7:30 - 8:30 pm

Networking, including meeting with Recruiting Event Sponsors at their Talent Tables

Speakers, Panelists and Moderators

Ben Hindson

KEYNOTE SPEAKER

James Langford

LIFE SCIENCES INVESTMENT LANDSCAPE

Sulatha Dwarakanath, PhD

PANEL DISCUSSION PARTICIPANT

John Hanna

PANEL DISCUSSION PARTICIPANT

FAQs

Who should attend?
Scientists, technologists, investors and business professionals working in industries that include or intersect with the life sciences who are entrepreneurs or have entrepreneurial ambitions.

Why should I attend?
This event is designed to relay information, inspiration, and create networking opportunities for the speakers and attendees.

How can I contact the organizers with any questions?
Please complete our contact form.

How do I register for the summit?
Head over to our Eventbrite .

How do I become a sponsor?
Please visit our Sponsorship page.

Photos From Our Previous Summit

2022 Sponsors & Affiliates

We are honored to partner with leading firms in the Tri-Valley who have demonstrated their commitment to growing the life sciences ecosystem in the region.

Host

Presenting Sponsors

Affiliates

Ecosystem Sponsors

Recruiting Sponsors

Event Sponsors

Become a Sponsor

2022 TVLSS Organizers

Brandon Cardwell

Innovation & Economic Development Director, City of Livermore
Executive Director, i-GATE Innovation Hub
Director, Startup Tri-Valley

Yolanda Fintschenko, Ph.D.

Co-founder, FounderTraction
Co-organizer, East Bay Bio Network

Don Arnold, Ph.D.

VP Bus Ops at General Inception
CEO at Veristad, LLC

Mitch Hertz

Executive Director at Cushman & Wakefield

Greg Hitchan

Co-Founder/Managing Partner at Tri-Valley Ventures

Mitch Levinson

Chief Strategy Officer & Board Member at Pulse Biosciences

Lauren Moone, CFA, CFP®, CPWA®

Executive Vice President at Mirador Capital Partners

Janelle Muranaka

Vice President of Operations at Meissa Vaccines

Brian Wilson

Office/R&D Leasing and Sales Advisor at Cushman & Wakefield

Location

Veeva System, the leading cloud-based software company serving the global life sciences industry, will once again host the Tri-Valley Life Sciences Summit at their headquarters in Pleasanton, CA.

Veeva Systems

4280 Hacienda Drive
Pleasanton, CA 94588

Connect with the Tri-Valley startup ecosystem

Let's Get Started

KEYNOTE SPEAKER

Ben Hindson

Co-founder and Chief Scientific Officer at 10x Genomics

Ben Hindson has served as Chief Scientific Officer and Director of 10x Genomics since its founding in 2012. Prior to 10x Genomics, he was Co-founder and Chief Scientific Officer of Quantalife, a privately-held life sciences company that developed and commercialized a droplet digital PCR platform, until its sale to Bio-Rad Laboratories in 2011. Before QuantaLife, Ben served in various positions of increasing responsibility at Lawrence Livermore National Laboratory in the Chemical and Biological Weapons Nonproliferation Program. He has published extensively in his field and holds numerous patents for assays and instrumentation. Ben earned his B.S. in Chemistry and his Ph.D in Chemistry from Deakin University, Australia.

LIFE SCIENCES INVESTMENT LANDSCAPE

James Langford

Principal at Tri-Valley Ventures

Tri-Valley Ventures is the only venture capital firm focused on funding and supporting early-stage companies in the Software, Life Sciences, and Deep Tech verticals in the Tri-Valley. James is responsible for conducting all aspects of due diligence involved in the investment decision-making process for prospective Tri-Valley Ventures investments. James’ experience includes providing over $1 billion in financing to 70+ innovative companies in both the earlier stage venture world and more mature middle-market.

James is passionate about supporting exceptional founders building breakthrough companies that are enabling people to live better, more fulfilling lives. If you're a founder, C-level executive, capital-provider, or intermediary in the space, please feel free to reach out and connect with James!

PANEL DISCUSSION PARTICIPANT

Sulatha Dwarakanath, PhD

Founder and CEO at Kaya17, Inc.

Sulatha is the Founder & CEO of Kaya17, Inc. and co-inventor of the Kaya17 platform technology, leading to development of a Point of Care, Rapid testing solution for COVID-19. As a serial entrepreneur, Dwarakanath has more than 25 years of experience in taking several products from bench to market under regulatory environment.

While working for various reputed companies such as Bayer Diagnostics (Siemens Heatheniers) and Thermo Fisher Scientific, she brought in various innovations that lead shorter time to market for critical diagnostics products. As a part Medical and Scientific Affairs, Assistant Director at Roche Molecular Systems, managed the Infectious Diseases group focused on HIV and Hepatitis.

Formerly, as the founder/CSO of Nano Science Diagnostics, Dwarakanath was instrumental in developing tests for bacteria in food and Point of Care tests for Strep and Staph with innovations in nanotechnology. She was the director of AC2 Bioscience Incubator in Austin TX, where she conceptualized the life science incubator, that currently hosts 12 companies and raised $10M from various government sources. As a part of National Science Foundation InnovATE BIO center, she co-chairs the National Industry and Workforce Advisory Council.

PANEL DISCUSSION PARTICIPANT

John Hanna

Chief Executive Officer at Apton Biosystems

John Hanna has led Apton Biosystems as Chief Executive Officer since 2021. Mr. Hanna has more than 20 years of senior healthcare management experience, including ten years at genomic diagnostics company Veracyte, Inc., where his roles included chief commercial officer and vice president of marketing. Prior to that, Mr. Hanna held sales and business development roles at IBM, Humana, Inc, and America’s Health Insurance Plans (AHIP)